Clinical Trial Update: Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating neoadjuvant chemoradiotherapy with either docetaxel or vinorelbine plus cisplatin for esophageal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Esophageal Squamous Cell Carcinoma, Esophageal Cancer | Phase 3 | Status: UNKNOWN